AI assistant
STAAR SURGICAL CO — Director's Dealing 2023
Jan 4, 2023
31996_dirs_2023-01-04_230367f4-6c37-4ce0-8dbe-dfe5b70752fd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2023-01-03
Reporting Person: FRINZI THOMAS G (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-01-03 | Common Shares | M | 87805 | $0.00 | Acquired | 92534 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | Common Stock Options | $51.25 | M | 160638 | Acquired | 2033-01-02 | Common Stock (160638) | Direct |
Footnotes
F1: Award of 87,805 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 29,268 of the RSUs on 1/3/24, 29,268 of the RSUs on 1/3/25, and 29,269 of the RSUs on 1/3/26.
F2: The options granted become exercisable as follows: 1/3 on 1/3/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 1/3/2026.